Necrotic cell death in atherosclerosis

Basic Research in Cardiology

Volumn 106, Issue 5, 2011, Pages 749-760

  Martinet, Wim ^a   Schrijvers, Dorien M ^a   De Meyer, Guido R Y ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; Cell death; Necrosis; Necrotic core

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; AZITHROMYCIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCIUM; CASPASE 9 INHIBITOR; CYCLOSPORIN A; CYCLOSPORIN A DERIVATIVE; DNA; HIGH MOBILITY GROUP B1 PROTEIN; INFLIXIMAB; INTERLEUKIN 6; LIPOXIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHYTOSTEROL; POLYMYXIN B; PROTEINASE; THROMBOMODULIN; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE; CELL ORGANELLE; CELL STRUCTURE; CELL SWELLING; CELL VOLUME; CYTOKINE RELEASE; DNA STRAND BREAKAGE; EDEMA; ENZYME ACTIVATION; ENZYME DEGRADATION; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; MEMBRANE RUPTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN SECRETION; RECEPTOR BINDING; REVIEW; SIDE EFFECT; TRANSMISSION ELECTRON MICROSCOPY; WEIGHT GAIN;

APOPTOSIS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; NECROSIS; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION;

EID: 80054694522     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0192-x     Document Type: Review

References (103)

1. Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, Esposito B, Teissier E, Daemen MJ, Leseche G, Boulanger C, Tedgui A, Mallat Z (2007) Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115:2168-2177. doi:10.1161/CIRCULATIONAHA.106.662080 (Pubitemid 46659069)
2. Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, Offenstadt G, Leseche G, Cohen PL, Tedgui A, Mallat Z (2008) Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 28:1429-1431. doi:10.1161/ATVBAHA.108.169078
3. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570. doi:10.1084/jem.192.4.565 (Pubitemid 30666257)
4. Bao L, Li Y, Deng SX, Landry D, Tabas I (2006) Sitosterolcontaining lipoproteins trigger free sterol-induced caspaseindependent death in ACAT-competent macrophages. J Biol Chem 281:33635-33649. doi:10.1074/jbc. M606339200 (Pubitemid 46036743)
5. Benko R, Pacher P, Vaslin A, Kollai M, Szabo C (2004) Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Life Sci 75:1255-1261. doi:10.1016/j.lfs.2004.04.007 (Pubitemid 38829350)
6. Beohar N, Flaherty JD, Davidson CJ, Maynard RC, Robbins JD, Shah AP, Choi JW, MacDonald LA, Jorgensen JP, Pinto JV, Chandra S, Klaus HM, Wang NC, Harris KR, Decker R, Bonow RO (2004) Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 109:108-113. doi:10.1161/01.CIR.0000105724.30980.CD (Pubitemid 38056030)
7. Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, Curtiss LK, Terkeltaub R (2006) Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 26:563-569. doi:10.1161/01.ATV.0000203503.82693.c1
8. Boyle JJ, Wilson B, Bicknell R, Harrower S, Weissberg PL, Fan TP (2000) Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol 192:234-242. doi:10.1002/1096-9896(2000)9999: 9999\:AIDPATH699[3.0.CO;2-9
9. Christofferson DE, Yuan J (2010) Cyclophilin A release as a biomarker of necrotic cell death. Cell Death Differ 17:1942-1943. doi:10.1038/cdd.2010.123
10. Crisby M, Kallin B, Thyberg J, Zhivotovsky B, Orrenius S, Kostulas V, Nilsson J (1997) Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130:17-27. doi:10.1016/S0021-9150(96) 06037-6 (Pubitemid 27158025)
11. Cuchacovich R, Espinoza LR (2009) Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients? Clin Rheumatol 28:1217-1220. doi:10.1007/s10067-009-1208-x
12. de Almeida CJ, Linden R (2005) Phagocytosis of apoptotic cells: a matter of balance. Cell Mol Life Sci 62:1532-1546. doi: 10.1007/s00018-005-4511-y (Pubitemid 41021577)
13. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP kinases at the crossroads of cell death and survival. Cell 138:229-232. doi:10.1016/j.cell. 2009.07.006
14. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, Arrigoni G, Bianchi ME (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152:1197-1206. doi:10.1083/jcb.152.6.1197 (Pubitemid 34280177)
15. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321. doi:10.1038/nchembio.83 (Pubitemid 351550892)
16. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119. doi:10.1038/nchembio711
17. Di Micco P, Ferrazzi P, Libre L, Mendolicchio L, Quaglia I, De Marco M, Colombo A, Bacci M, Rota LL, Lodigiani C (2009) Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis. Int J Gen Med 2:141-144. doi:10.2147/IJGM.S5178
18. Doran JP, Howie AJ, Townend JN, Bonser RS (1996) Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. J Clin Pathol 49:34-37. doi:10.1136/jcp.49.1.34 (Pubitemid 26034144)
19. Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, Hakimi M, Bockler D, Katus HA, Gleissner CA (2011) Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.Basic Res Cardiol 106:125-134. doi:10.1007/s00395-010-0135-y
20. Erdmann E, Charbonnel B, Wilcox R (2009) Thiazolidinediones and cardiovascular risk-a question of balance. Curr Cardiol Rev 5:155-165. doi:10.2174/157340309788970333
21. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562-1569. doi:10.1016/0735-1097 (94)90657-2 (Pubitemid 24182120)
22. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P (2007) RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 14:400-410
23. Festjens N, Vanden Berghe T, Vandenabeele P (2006) Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 1757:1371-1387. doi:10.1016/j.bbabio.2006.06.014 (Pubitemid 44472550)
24. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652-2660. doi:10.1182/blood-2002-05- 1300 (Pubitemid 36857626)
25. Freudenberger T, Oppermann M, Heim HK, Mayer P, Kojda G, Schror K, Fischer JW (2010) Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol 105:479-486. doi: 10.1007/s00395-010-0091-6
26. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocytederived macrophages. J Immunol 164:1663-1667 (Pubitemid 30108713)
27. Gossl M, Herrmann J, Tang H, Versari D, Galili O, Mannheim D, Rajkumar SV, Lerman LO, Lerman A (2009) Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol 104:695-706. doi:10.1007/s00395-009-0036-0
28. Guyton JR, Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16:4-11 (Pubitemid 26026925)
29. Hans CP, Feng Y, Naura AS, Zerfaoui M, Rezk BM, Xia H, Kaye AD, Matrougui K, Lazartigues E, Boulares AH (2009) Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress. PLoS One 4:e7430. doi:10.1371/journal.pone.0007430
30. Hans CP, Zerfaoui M, Naura AS, Catling A, Boulares AH (2008) Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability. Cardiovasc Res 78:429-439. doi:10.1093/cvr/cvn018 (Pubitemid 351769756)
31. Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, Reynolds PN (2006) Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J 28:486-495. doi:10.1183/09031936.06.00001506 (Pubitemid 44794662)
32. Inoue K, Kawahara K, Biswas KK, Ando K, Mitsudo K, Nobuyoshi M, Maruyama I (2007) HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 16:136-143. doi:10.1016/j.carpath.2006.11.006 (Pubitemid 46729668)
33. Jacobsson LT, Turesson C, Gulfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213-1218 (Pubitemid 40995372)
34. Jialal I, Devaraj S (2003) Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107:926-928. doi:10.1161/01.CIR. 0000048966.26216.4C (Pubitemid 36258710)
35. Jin ZG, Lungu AO, Xie L, Wang M, Wong C, Berk BC (2004) Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 24:1186-1191. doi:10.1161/01.ATV.0000130664.51010.28 (Pubitemid 38880006)
36. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G, Ilyinskaya O, Tararak E, Bobik A (2004) Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 24:2320-2325. doi: 10.1161/01.ATV.0000145573.36113.8a (Pubitemid 39658036)
37. Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, Mori S, Takahashi HK, Liu K, Peter K, Nishibori M, Bobik A (2011) High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31:313-319. doi:10.1161/ATVBAHA.110.218669
38. Katsuda S, Kaji T (2003) Atherosclerosis and extracellular matrix. J Atheroscler Thromb 10:267-274
39. Kim SH, Lessner SM, Sakurai Y, Galis ZS (2004) Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 164:1567-1574. doi:10.1016/S0002-9440(10)63715-7 (Pubitemid 38529759)
40. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295-314. doi:10.1016/j.pharmthera.2010.05.002
41. Kockx M, Jessup W, Kritharides L (2010) Cyclosporin A and atherosclerosis-cellular pathways in atherogenesis. Pharmacol Ther 128:106-118. doi:10.1016/j.pharmthera.2010.06.001
42. Kockx MM, Herman AG (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45:736-746. doi: 10.1016/S0008-6363(99)00235-7 (Pubitemid 30047141)
43. Konstandin MH, Aksoy H, Wabnitz GH, Volz C, Erbel C, Kirchgessner H, Giannitsis E, Katus HA, Samstag Y, Dengler TJ (2009) Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris. Basic Res Cardiol 104:341-351. doi:10.1007/s00395-008-0770-8
44. Krysko DV, Denecker G, Festjens N, Gabriels S, Parthoens E, D'Herde K, Vandenabeele P (2006) Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ 13:2011-2022. doi:10.1038/sj.cdd.4401900 (Pubitemid 44742684)
45. Kunishima A, Takemura G, Takatsu H, Hayakawa Y, Kanoh M, Qiu X, Fujiwara T, Fujiwara H (1999) Mode and role of cell death during progression of atherosclerotic lesions in hypercholesterolemic rabbits. Heart Vessels 14:295-306 (Pubitemid 30342830)
46. Li S, Sun Y, Liang CP, Thorp EB, Han S, Jehle AW, Saraswathi V, Pridgen B, Kanter JE, Li R, Welch CL, Hasty AH, Bornfeldt KE, Breslow JL, Tabas I, Tall AR (2009) Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 105:1072-1082. doi:10.1161/CIRCRESAHA.109.199570
47. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM (2004) Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol 37:969-978. doi: 10.1016/j.yjmcc.2004.07.009 (Pubitemid 39446822)
48. Lundberg B (1985) Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 56:93-110. doi: 10.1016/0021-9150(85)90087-5 (Pubitemid 15049652)
49. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241. doi: 10.1038/35025203
50. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29-38. doi:10.1161/01.ATV.0000150649. 39934.13 (Pubitemid 40054251)
51. Maderna P, Godson C (2003) Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 1639:141-151. doi:10.1016/j.bbadis.2003.09.004 (Pubitemid 37421421)
52. Malesevic M, Kuhling J, Erdmann F, Balsley MA, Bukrinsky MI, Constant SL, Fischer G (2010) A cyclosporin derivative discriminates between extracellular and intracellular cyclophilins. Angew Chem Int Ed Engl 49:213-215. doi:10.1002/anie.200904529
53. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348-353 (Pubitemid 29051259)
54. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106:927-932. doi:10.1161/01.CIR.0000026393. 47805.21 (Pubitemid 34925325)
55. Meilhac O, Escargueil-Blanc I, Thiers JC, Salvayre R, Negre-Salvayre A (1999) Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J 13:485-494 (Pubitemid 29115566)
56. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176:7657-7665 (Pubitemid 43849066)
57. Murdaca G, Colombo BM, Puppo F (2009) Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 22:557-565
58. Nagy N, Melchior-Becker A, Fischer JW (2010) Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis. Basic Res Cardiol 105:29-38. doi:10.1007/s00395-009-0051-1
59. Nazzal D, Cantero AV, Therville N, Segui B, Negre-Salvayre A, Thomsen M, Benoist H (2006) Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. J Infect Dis 193:136-145. doi:10.1086/498617 (Pubitemid 43032509)
60. Nigro P, Satoh K, O'Dell MR, Soe NN, Cui Z, Mohan A, Abe J, Alexis JD, Sparks JD, Berk BC (2011) Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 208:53-66. doi: 10.1084/jem.20101174
61. Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH (2007) Poly(-ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 115:2442-2450. doi:10.1161/CIRCULATIONAHA.106.668756 (Pubitemid 46717967)
62. Pacher P, Szabo C (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25:235-260. doi: 10.1111/j.1527-3466.2007.00018.x (Pubitemid 47547464)
63. Peng TI, Jou MJ (2010) Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 1201:183-188. doi: 10.1111/j.1749-6632.2010.05634.x
64. Phair RD (1988) Cellular calcium and atherosclerosis: a brief review. Cell Calcium 9:275-284. doi:10.1016/0143-4160(88)90008-5 (Pubitemid 19026984)
65. Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL, Radstake TR, Netea MG, Roest M, Stalenhoef AF (2009) Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis 68:868-872. doi:10.1136/ard.2008.092171
66. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, Bianchi ME (2006) Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 20:2565-2566. doi:10.1096/fj.06-5867fje (Pubitemid 44953782)
67. Postlethwaite AE, Kang AH (1976) Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med 143:1299-1307
68. Rock KL, Kono H (2008) The inflammatory response to cell death. Annu Rev Pathol 3:99-126. doi:10.1146/annurev. pathmechdis.3.121806.151456 (Pubitemid 351488277)
69. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H (2007) Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 81:49-58. doi:10.1189/jlb.0306200 (Pubitemid 46021252)
70. Saelens X, Festjens N, Parthoens E, Vanoverberghe I, Kalai M, van Kuppeveld F, Vandenabeele P (2005) Protein synthesis persists during necrotic cell death. J Cell Biol 168:545-551. doi: 10.1083/jcb.200407162 (Pubitemid 40271019)
71. Sarai M, Hartung D, Petrov A, Zhou J, Narula N, Hofstra L, Kolodgie F, Isobe S, Fujimoto S, Vanderheyden JL, Virmani R, Reutelingsperger C, Wong ND, Gupta S, Narula J (2007) Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging. J Am Coll Cardiol 50:2305-2312. doi: 10.1016/j.jacc.2007.08. 044 (Pubitemid 350192104)
72. Satoh K, Matoba T, Suzuki J, O'Dell MR, Nigro P, Cui Z, Mohan A, Pan S, Li L, Jin ZG, Yan C, Abe J, Berk BC (2008) Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 117:3088-3098. doi:10.1161/CIRCULATIONAHA.107.756106
73. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195. doi:10.1038/nature00858 (Pubitemid 34773774)
74. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177:1272-1281 (Pubitemid 44036633)
75. Schrijvers DM, De Meyer GRY, Kockx MM, Herman AG, Martinet W (2005) Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25:1256-1261. doi:10.1161/01.ATV.0000166517.18801. a7 (Pubitemid 40776618)
76. Seeger FH, Sedding D, Langheinrich AC, Haendeler J, Zeiher AM, Dimmeler S (2010) Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression. Basic Res Cardiol 105:389-397. doi:10.1007/s00395-009-0072-9
77. Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, Tall AR, Tabas IA (2009) Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest 119:886-898. doi:10.1172/JCI37262
78. Senior RM, Griffin GL, Mecham RP (1980) Chemotactic activity of elastin-derived peptides. J Clin Invest 66:859-862. doi:10.1172/JCI109926 (Pubitemid 10060957)
79. Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW (1984) Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 99:870-874. doi:10.1083/jcb.99.3.870 (Pubitemid 14043344)
80. Sherry B, Yarlett N, Strupp A, Cerami A (1992) Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc Natl Acad Sci USA 89:3511-3515. doi:10.1073/pnas.89. 8.3511
81. Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, Tan H, Pan X, Wu Z (2009) Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogenactivated protein kinase pathways. Basic Res Cardiol 104:42-49. doi:10.1007/s00395-008-0738-8
82. Suzuki J, Jin ZG, Meoli DF, Matoba T, Berk BC (2006) Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 98:811-817. doi:10.1161/01. RES.0000216405.85080.a6
83. Szondy Z, Sarang Z, Molnar P, Nemeth T, Piacentini M, Mastroberardino PG, Falasca L, Aeschlimann D, Kovacs J, Kiss I, Szegezdi E, Lakos G, Rajnavolgyi E, Birckbichler PJ, Melino G, Fesus L (2003) Transglutaminase 2-/-mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA 100:7812-7817. doi:10.1073/pnas.0832466100 (Pubitemid 36760052)
84. Tabas I (2005) Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 25:2255-2264. doi:10.1161/01.ATV. 0000184783.04864.9f (Pubitemid 41552640)
85. Tabas I (2007) Apoptosis and efferocytosis in mouse models of atherosclerosis. Curr Drug Targets 8:1288-1296. doi:10.2174/138945007783220623
86. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079-17084. doi:10.1074/jbc.M310859200 (Pubitemid 38560463)
87. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I (2008) Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/-mice. Arterioscler Thromb Vasc Biol 28:1421-1428. doi:10.1161/ATVBAHA.108.167197
88. Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I (2007) Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic lowdensity lipoprotein receptor-null mice. Circulation 116:2182-2190. doi:10.1161/CIRCULATIONAHA.107.698852 (Pubitemid 350060356)
89. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, Tabas I (2009) Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/-and Ldlr-/-mice lacking CHOP. Cell Metab 9:474-481. doi:10.1016/j.cmet.2009.03.003
90. Thorp E, Li Y, Bao L, Yao PM, Kuriakose G, Rong J, Fisher EA, Tabas I (2009) Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/-mice lacking macrophage Bcl-2. Arterioscler Thromb Vasc Biol 29:169-172. doi:10.1161/ATVBAHA.108.176495
91. Tiyerili V, Zimmer S, Jung S, Wassmann K, Naehle CP, Lutjohann D, Zimmer A, Nickenig G, Wassmann S (2010) CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol 105:465-477. doi:10.1007/s00395-010- 0090-7
92. Tyurina YY, Serinkan FB, Tyurin VA, Kini V, Yalowich JC, Schroit AJ, Fadeel B, Kagan VE (2004) Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J Biol Chem 279:6056-6064. doi: 10.1074/jbc.M309929200 (Pubitemid 38220638)
93. Ulloa L, Messmer D (2006) High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 17:189-201. doi:10.1016/j.cytogfr. 2006.01.003 (Pubitemid 43949075)
94. Van Herck JL, De Meyer GRY, Martinet W, Bult H, Vrints CJ, Herman AG (2010) Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Basic Res Cardiol 105:39-50. doi:10.1007/s00395-009- 0054-y
95. Van Herck JL, De Meyer GRY, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van Der Veken P, Van Vaeck L, Bult H, Herman AG, Vrints CJ (2010) Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol 105:51-59. doi:10.1007/s00395-009-0052-0
96. Vanden Berghe T, Kalai M, Denecker G, Meeus A, Saelens X, Vandenabeele P (2006) Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal 18:328-335. doi: 10.1016/j.cellsig.2005.05.003 (Pubitemid 41661348)
97. Vejux A, Lizard G (2009) Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 30:153-170. doi:10.1016/j.mam.2009.02.006
98. Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M (2009) Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr Med Chem 16:4654-4667. doi:10.2174/092986709789878265
99. Virmani R, Burke A, Willerson J, Farb A, Narula J, Kolodgie F (2007) The pathology of vulnerable plaque. In: Virmani R, Narula J, Leon M, Willerson J (eds) The vulnerable atherosclerotic plaque: strategies for diagnosis and management. Blackwell Futura, Malden, pp 21-36
100. Wei Y, Heng G, BenH(2010) Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes. Atherosclerosis 213:415-421. doi:10.1016/j.atherosclerosis.2010.09.033
101. Yang H, Tracey KJ (2010) Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799:149-156. doi:10.1016/j.bbagrm.2009.11.019
102. Yang H, Wang H, Czura CJ, Tracey KJ (2005) The cytokine activity of HMGB1. J Leukoc Biol 78:1-8. doi:10.1189/jlb.1104648 (Pubitemid 40979937)
103. Yang J, Huang C, Yang J, Jiang H, Ding J (2011) Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-kappaB signaling pathway. Mol Cell Biochem 345:189-195. doi: 10.1007/s11010-010-0572-9